The formation of a crosslinked carboxyhemoglobin membrane at an organic-aqueous interface

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 24, Issue 3, 1996, Pages 185-196

  Eisman, Jill Marcia ^a   Schnaare, Roger L ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; ALDEHYDES; BIOLOGICAL MEMBRANES; BLOOD; CELLS; CROSSLINKING; ESTERS; HEMOGLOBIN; MECHANICAL PERMEABILITY; PHASE INTERFACES; PHOSPHATES; TOLUENE;

CARBOXYHEMOGLOBIN MEMBRANE; DISUCCINIMIDYL GLUTARATE; DISUCCINIMIDYL SUBERATE; RED BLOOD CELL; TEREPHTHALDICARBOXALDEHYDE;

BLOOD SUBSTITUTES;

CARBOXYHEMOGLOBIN; DISUCCINIMIDYL GLUTARATE; GLUTARALDEHYDE; SUBERIC ACID BIS(N HYDROXYSUCCINIMIDE) ESTER; TEREPHTHALDICARBOXALDEHYDE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; ENCAPSULATION; ERYTHROCYTE; MEMBRANE PERMEABILITY;

EID: 0029885403     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199609117434     Document Type: Article

References (11)

1. W. R. Amberson, J. Flexner, F. R. Steggerda, A. G. Mulder, M. J. Tendler, D. S. Pankratz, R. E. Lang. On the use of Ringer-Locke solution containing hemoglobin for normal blood in mammals, J. Cell Comp. Physiol. 5:359 (1934).
2. T. M. S. Chang and P. E. Keipert. Pyridoxylated-polyhemoglobin solution: a low viscosity oxygen-delivering blood replacement fluid with normal oncotic pressure and long term storage feasibility. In T. M. S. Chang and R, Geyer (eds.), Biomaterials, Artificial Cells, and Artificial Organs, 16 (1-3), Marcel Dekker, Inc., New York, 1988, pp. 185-196.
3. H. W. Wallace, W. J. Asher, and T. A. Davis. Artificial red cells with crosslinked hemoglobin membranes. Appl. Biochem. and Biotech. 10:123-132 (1984).
4. S.M. Waugh, E. E. DiBella, and P. F. Pilch. Isolation of a proteolytically derived domain of the insulin receptor containing the major site of crosslinking/binding. Biochemistry. 28:3448-3455 (1989).
5. S. R. Synder, E. V. Welty, R. Y. Walder, L. A. Williams, and J. A. Walder. HbXL99αα: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc. Natl. Acad. Sci. 84:7280-7284 (1987).
6. E. E. Iorio. Preparation of derivatives of ferrous and ferric hemoglobin. In E. Antononi, L. Rossi-Bernardi, and E. Chiancone (eds.), Methods in Enzymology, 76, Academic Press, New York, 1981, pp.57-71.
7. P. E. Keipert, A. J. Adeniran, S. Kwong, and R. E. Benesch. Functional properties of a new crosslinked hemoglobin designed for use as a red cell substitute. Transfusion. 29:768-773 (1989).
8. Y. Ikada and Y. Tabata. Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres. J. Pharm. Pharmacol. 39:698-704 (1987).
9. E. Sawicki, T. R. Hanser, T. W. Stanley, and W. Elbert. The 3-methyl-2-benzothiazolone hydrazone test. Anal. Chem. 33:93-96 (1961).
10. L. Tentori and A.M. Salvati. Determination of aberrant hemoglobin derivatives in human blood. In E. Antononi, L. Rossi-Bernardi, and E. Chiancone (eds.), Methods in Enzymology, 76, Academic Press, New York, 1981, pp. 715-731.
11. H. B. Kostenbauder and J. B. Bogardus. Reaction Kinetics. In A. Gennaro (ed.), Remington's Pharmaceutical Sciences, Mack Publishing Co., Easton, Pa., 1990, pp. 247-257.